Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an…

Overview of attention for article published in Arthritis Research & Therapy, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 5 news stories from 4 outlets.

Inibire l'attivit macrofagica utilizzando, come bersaglio terapeutico, il Fattore stimolante le colonie granulocitarie-macrofagic…

medwireNews: Namilumab induces a rapid and sustained clinically significant response in patients with moderate-to-severe…

medwireNews: Namilumab induces a rapid and sustained clinically significant response in patients with moderate-to-severe…

Namilumab, a monoclonal antibody that targets the granulocyte-macrophage colony-stimulating factor () ligand, showed promise as…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 1 additional news stories.